Inhibition of Thyrotropin-Stimulated Iodide Uptake in FRTL-5 Thyroid Cells by Crude Immunoglobulin Fractions from Patients With Goitrous and Atrophic Autoimmune Thyroiditis*
- 1 August 1988
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 67 (2) , 251-258
- https://doi.org/10.1210/jcem-67-2-251
Abstract
We studied the effects of crude immunoglobulin (Ig) fractions of serum from patients with goitrous and atrophic autoimmune thyroiditis on TSH-, thyroid-stimulating immunoglobulin (TSI)-, forskolin-, and dibutyryl cAMP-stimulated 125I uptake by FRTL-5 thyroid cells. TSH-stimulated 125I uptake was inhibited by the Ig fractions from 15 patients with atrophic thyroiditis who had serum TSH binding inhibitor Igs (TBII), 10 (62.5%) of 16 TBII-negative patients with atrophic thyroiditis, 7 (43.8%) of 16 hypothyroid patients with goitrous thyroiditis who had no TBII activity, and only 2 (15.4%) of 13 euthyroid patients with goitrous thyroiditis who were negative for TBII. The mean inhibition of TSH-stimulated 125I uptake produced by the crude Igs from the former 3 groups of hypothyroid patients was statistically significant (P < 0.001, P < 0.001, and P < 0.01, respectively) and correlated closely with the ability of the Ig fractions to inhibit TSI-stimulated 125I uptake (r = 0.882) and TSH-stimulated cAMP accumulation (r = 0.929). The inhibition of TSH- or TSI-stimulated 125I uptake by Ig samples containing TBII correlated significantly with the TBII activities. On the other hand, in the presence of Igs from TBII-negative hypothyroid patients, the inhibition of TSH-stimulated l25I uptake correlated significantly with that of forskolin-stimulated 125I uptake (r = 0.685). Although 6 (12.8%) of 47 Ig samples from hypothyroid patients inhibited dibutyryl cAMP-stimulated 125I uptake, the activities were marginal. These findings suggest that at least 2 types of antibodies are involved in the inhibition of TSH- or TSI-stimulated 125I uptake: 1 being a competitive inhibitor of TSH binding to its receptors, and another exerting influence on a step subsequent to TSH or TSI binding, presumably through adenylate cyclase inhibition.Keywords
This publication has 20 references indexed in Scilit:
- Primary Myxedema with Thyrotrophin-Binding Inhibitor ImmunoglobulinsAnnals of Internal Medicine, 1985
- TWO TYPES OF THYROID FUNCTION‐BLOCKING ANTIBODIES IN AUTOIMMUNE ATROPHIC THYROIDITIS AND TRANSIENT NEONATAL HYPOTHYROIDISM DUE TO MATERNAL IgGClinical Endocrinology, 1984
- Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism.BMJ, 1984
- Iodide Transport in a Continuous Line of Cultured Cells from Rat ThyroidEndocrinology, 1984
- Graves’ IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: A clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid diseaseJournal of Endocrinological Investigation, 1983
- Inhibition of Thyrotropin-Induced Adenosine 3′5′-Monophosphate Increase by Immunoglobulins from Patients with Primary Myxedema*Journal of Clinical Endocrinology & Metabolism, 1983
- Sequential Serum Measurements of Thyrotropin Binding Inhibitor Immunoglobulin G in Transient Familial Neonatal HypothyroidismJournal of Clinical Endocrinology & Metabolism, 1983
- Development and Evaluation of a Method for the Partial Purification of Immunoglobulins Specific for Graves’ Disease*Journal of Clinical Endocrinology & Metabolism, 1981
- Culture of hormone-dependent functional epithelial cells from rat thyroids.Proceedings of the National Academy of Sciences, 1980
- Detection and Properties of TSH-Binding Inhibitor Immunoglobulins in Patients with Graves’ Disease and Hashimoto’s Thyroiditis*Journal of Clinical Endocrinology & Metabolism, 1978